rs116474260

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000171.4(GLRA1):​c.1108G>A​(p.Gly370Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0124 in 1,613,434 control chromosomes in the GnomAD database, including 137 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G370G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0093 ( 7 hom., cov: 31)
Exomes 𝑓: 0.013 ( 130 hom. )

Consequence

GLRA1
NM_000171.4 missense

Scores

1
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:13

Conservation

PhyloP100: 3.92

Publications

13 publications found
Variant links:
Genes affected
GLRA1 (HGNC:4326): (glycine receptor alpha 1) The protein encoded by this gene is a subunit of a pentameric inhibitory glycine receptor, which mediates postsynaptic inhibition in the central nervous system. Defects in this gene are a cause of startle disease (STHE), also known as hereditary hyperekplexia or congenital stiff-person syndrome. Multiple transcript variants encoding different isoforms have been found. [provided by RefSeq, Dec 2015]
GLRA1 Gene-Disease associations (from GenCC):
  • hyperekplexia 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000171.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00745064).
BP6
Variant 5-151822915-C-T is Benign according to our data. Variant chr5-151822915-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 38327.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00932 (1419/152242) while in subpopulation NFE AF = 0.0148 (1007/68012). AF 95% confidence interval is 0.014. There are 7 homozygotes in GnomAd4. There are 691 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000171.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLRA1
NM_000171.4
MANE Select
c.1108G>Ap.Gly370Ser
missense
Exon 9 of 9NP_000162.2P23415-2
GLRA1
NM_001146040.2
c.1132G>Ap.Gly378Ser
missense
Exon 9 of 9NP_001139512.1P23415-1
GLRA1
NM_001292000.2
c.859G>Ap.Gly287Ser
missense
Exon 8 of 8NP_001278929.1Q14C71

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLRA1
ENST00000274576.9
TSL:1 MANE Select
c.1108G>Ap.Gly370Ser
missense
Exon 9 of 9ENSP00000274576.5P23415-2
GLRA1
ENST00000455880.2
TSL:1
c.1132G>Ap.Gly378Ser
missense
Exon 9 of 9ENSP00000411593.2P23415-1
GLRA1
ENST00000462581.6
TSL:1
n.*866G>A
non_coding_transcript_exon
Exon 8 of 8ENSP00000430595.1E5RJ70

Frequencies

GnomAD3 genomes
AF:
0.00933
AC:
1419
AN:
152124
Hom.:
7
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00246
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.00864
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00580
Gnomad FIN
AF:
0.00565
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.00962
AC:
2412
AN:
250714
AF XY:
0.00972
show subpopulations
Gnomad AFR exome
AF:
0.00222
Gnomad AMR exome
AF:
0.00553
Gnomad ASJ exome
AF:
0.00889
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00598
Gnomad NFE exome
AF:
0.0153
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
AF:
0.0127
AC:
18541
AN:
1461192
Hom.:
130
Cov.:
32
AF XY:
0.0125
AC XY:
9074
AN XY:
726808
show subpopulations
African (AFR)
AF:
0.00260
AC:
87
AN:
33454
American (AMR)
AF:
0.00595
AC:
266
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00847
AC:
221
AN:
26084
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39684
South Asian (SAS)
AF:
0.00521
AC:
449
AN:
86242
European-Finnish (FIN)
AF:
0.00573
AC:
306
AN:
53408
Middle Eastern (MID)
AF:
0.0279
AC:
161
AN:
5766
European-Non Finnish (NFE)
AF:
0.0147
AC:
16361
AN:
1111482
Other (OTH)
AF:
0.0114
AC:
688
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
925
1850
2774
3699
4624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
584
1168
1752
2336
2920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00932
AC:
1419
AN:
152242
Hom.:
7
Cov.:
31
AF XY:
0.00928
AC XY:
691
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00246
AC:
102
AN:
41540
American (AMR)
AF:
0.00863
AC:
132
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.00601
AC:
29
AN:
4826
European-Finnish (FIN)
AF:
0.00565
AC:
60
AN:
10612
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0148
AC:
1007
AN:
68012
Other (OTH)
AF:
0.0142
AC:
30
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
78
155
233
310
388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
63
Bravo
AF:
0.00922
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0155
EpiControl
AF:
0.0160

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
6
Hyperekplexia 1 (7)
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
GLRA1-related disorder (1)
-
-
1
Hereditary hyperekplexia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
24
DANN
Uncertain
0.99
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.075
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0075
T
MetaSVM
Benign
-0.53
T
MutationAssessor
Benign
1.9
L
PhyloP100
3.9
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.24
Sift
Benign
0.11
T
Sift4G
Benign
0.35
T
Varity_R
0.21
gMVP
0.59
Mutation Taster
=30/70
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs116474260;
hg19: chr5-151202476;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.